BIOMAT Database Logo BIOMAT Database Logo

[Comparative study of insulins Novo Monotard and Lente MC]. 1979

A Scheen, and M Scheen-Lavigne, and A Luyckx

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D049528 Insulin, Long-Acting Insulin formulations that contain substances that retard absorption thus extending the time period of action. Insulin, Semilente,Long-Acting Insulin,Insulin, Long Acting,Long Acting Insulin,Semilente Insulin

Related Publications

A Scheen, and M Scheen-Lavigne, and A Luyckx
[Immunogenicity of MC Lente Novo insulin].
September 1986, Polskie Archiwum Medycyny Wewnetrznej,
A Scheen, and M Scheen-Lavigne, and A Luyckx
The lente insulins.
January 1956, Diabetes,
A Scheen, and M Scheen-Lavigne, and A Luyckx
The new lente insulins.
October 1953, Journal of the Irish Medical Association,
A Scheen, and M Scheen-Lavigne, and A Luyckx
[Insulin Monotard and Insulin Lente. Comparison of absorption and clinical effects].
October 1975, Ugeskrift for laeger,
A Scheen, and M Scheen-Lavigne, and A Luyckx
OBSERVATIONS ON THE LENTE INSULINS.
March 1964, Scottish medical journal,
A Scheen, and M Scheen-Lavigne, and A Luyckx
Assessment of diabetic control with Actrapid and Monotard insulins.
June 1980, The Practitioner,
A Scheen, and M Scheen-Lavigne, and A Luyckx
Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
January 1977, Panminerva medica,
A Scheen, and M Scheen-Lavigne, and A Luyckx
Comparison of twice daily regimens of Actrapid and Monotard insulins.
March 1985, East African medical journal,
A Scheen, and M Scheen-Lavigne, and A Luyckx
The lente insulins, insulin-zinc suspensions.
October 1954, Danish medical bulletin,
A Scheen, and M Scheen-Lavigne, and A Luyckx
Further experience with the lente insulins.
June 1958, British medical journal,
Copied contents to your clipboard!